Researchers have discovered a new role for the bioactive lipid messenger, sphingosine-1-phosphate, or S1P, that is abundant in our blood — a finding that could lead to a new generation of drugs to fight cancer and inflammatory disease.
Researchers have discovered a new role for the bioactive lipid messenger, sphingosine-1-phosphate, or S1P, that is abundant in our blood — a finding that could lead to a new generation of drugs to fight cancer and inflammatory disease.